Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoid and opioid interactions: Implications for opiate dependence and withdrawal
Jillian L. Scavone, Robert C. Sterling, Elisabeth J. Van Bockstaele
Neuroscience (2013) Vol. 248, pp. 637-654
Open Access | Times Cited: 185

Showing 1-25 of 185 citing articles:

Medical Cannabis Laws and Opioid Analgesic Overdose Mortality in the United States, 1999-2010
Marcus A. Bachhuber, Brendan Saloner, Chinazo O. Cunningham, et al.
JAMA Internal Medicine (2014) Vol. 174, Iss. 10, pp. 1668-1668
Open Access | Times Cited: 662
Neonatal Abstinence Syndrome
Prabhakar Kocherlakota
PEDIATRICS (2014) Vol. 134, Iss. 2, pp. e547-e561
Closed Access | Times Cited: 572
Neurobiology of Opioid Addiction: Opponent Process, Hyperkatifeia, and Negative Reinforcement
George F. Koob
Biological Psychiatry (2019) Vol. 87, Iss. 1, pp. 44-53
Closed Access | Times Cited: 396
The effect of medical marijuana laws on adolescent and adult use of marijuana, alcohol, and other substances
Hefei Wen, Jason M. Hockenberry, Janet R. Cummings
Journal of Health Economics (2015) Vol. 42, pp. 64-80
Closed Access | Times Cited: 353
Cannabinoids and Pain: New Insights From Old Molecules
Sonja Vučković, Dragana Srebro, Katarina Savić Vujović, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 300
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
George F. Koob
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 163-201
Open Access | Times Cited: 237
The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9472-9472
Open Access | Times Cited: 201
Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals
Christopher A. Legare, Wesley M. Raup‐Konsavage, Kent E. Vrana
Pharmacology (2022) Vol. 107, Iss. 3-4, pp. 131-149
Open Access | Times Cited: 172
ASRA Pain Medicine consensus guidelines on the management of the perioperative patient on cannabis and cannabinoids
Shalini Shah, Eric S. Schwenk, Rakesh V. Sondekoppam, et al.
Regional Anesthesia & Pain Medicine (2023) Vol. 48, Iss. 3, pp. 97-117
Open Access | Times Cited: 58
Emerging Evidence for Cannabis' Role in Opioid Use Disorder
Beth M. Wiese, Adrianne R. Wilson‐Poe
Cannabis and Cannabinoid Research (2018) Vol. 3, Iss. 1, pp. 179-189
Open Access | Times Cited: 137
Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling
G Grabner, Robert Zimmermann, Rudolf Schicho, et al.
Pharmacology & Therapeutics (2017) Vol. 175, pp. 35-46
Open Access | Times Cited: 122
Safety and Pharmacokinetics of Oral Cannabidiol When Administered Concomitantly With Intravenous Fentanyl in Humans
Alex F. Manini, Georgia Yiannoulos, Mateus M. Bergamaschi, et al.
Journal of Addiction Medicine (2015) Vol. 9, Iss. 3, pp. 204-210
Open Access | Times Cited: 116
Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies
Befort Katia
Frontiers in Pharmacology (2015) Vol. 6
Open Access | Times Cited: 113
Endocannabinoid signaling and food addiction
Claudio D’Addario, Maria Vittoria Micioni Di Bonaventura, Mariangela Pucci, et al.
Neuroscience & Biobehavioral Reviews (2014) Vol. 47, pp. 203-224
Closed Access | Times Cited: 112
Medical marijuana laws and adolescent use of marijuana and other substances: Alcohol, cigarettes, prescription drugs, and other illicit drugs
Magdalena Cerdá, Aaron L. Sarvet, Melanie M. Wall, et al.
Drug and Alcohol Dependence (2017) Vol. 183, pp. 62-68
Open Access | Times Cited: 99
Some Prospective Alternatives for Treating Pain: The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55
Raquel Guerrero‐Alba, Paulino Barragán‐Iglesias, Abimael González‐Hernández, et al.
Frontiers in Pharmacology (2019) Vol. 9
Open Access | Times Cited: 88
Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses
Zeinab Breijyeh, Buthaina Jubeh, Sabino Aurelio Bufo, et al.
Toxins (2021) Vol. 13, Iss. 2, pp. 117-117
Open Access | Times Cited: 84
Opportunities for cannabis in supportive care in cancer
Amber S. Kleckner, Ian R. Kleckner, Charles Kamen, et al.
Therapeutic Advances in Medical Oncology (2019) Vol. 11
Open Access | Times Cited: 82
Elevated Norepinephrine may be a Unifying Etiological Factor in the Abuse of a Broad Range of Substances: Alcohol, Nicotine, Marijuana, Heroin, Cocaine, and Caffeine
Paul J. Fitzgerald
Substance Abuse Research and Treatment (2013) Vol. 7
Open Access | Times Cited: 85
The effects of dronabinol during detoxification and the initiation of treatment with extended release naltrexone
Adam Bisaga, Maria A. Sullivan, Andrew Glass, et al.
Drug and Alcohol Dependence (2015) Vol. 154, pp. 38-45
Open Access | Times Cited: 83
Impact of Medical Marijuana Laws on State-Level Marijuana Use by Age and Gender, 2004–2013
Christine Mauro, Paul Newswanger, Julián Santaella-Tenorio, et al.
Prevention Science (2017) Vol. 20, Iss. 2, pp. 205-214
Open Access | Times Cited: 82
High‐intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis
M. Eugenia Socías, Evan Wood, Stephanie Lake, et al.
Addiction (2018) Vol. 113, Iss. 12, pp. 2250-2258
Open Access | Times Cited: 64
Δ9-tetrahydrocannabinol attenuates oxycodone self-administration under extended access conditions
Jacques D. Nguyen, Yanabel Grant, Kevin M. Creehan, et al.
Neuropharmacology (2019) Vol. 151, pp. 127-135
Open Access | Times Cited: 58
Positive Allosteric Modulation of CB1 Cannabinoid Receptor Signaling Enhances Morphine Antinociception and Attenuates Morphine Tolerance Without Enhancing Morphine- Induced Dependence or Reward
Richard A. Slivicki, Vishakh Iyer, Sonali S. Mali, et al.
Frontiers in Molecular Neuroscience (2020) Vol. 13
Open Access | Times Cited: 57
Medical Cannabis for the Management of Pain and Quality of Life in Chronic Pain Patients: A Prospective Observational Study
Ramin Safakish, Gordon Ko, Vahid Salimpour, et al.
Pain Medicine (2020) Vol. 21, Iss. 11, pp. 3073-3086
Closed Access | Times Cited: 56
Page 1 - Next Page

Scroll to top